Adding a new medication to standard treatment for inflammatory bowel disease

This trial is testing whether a medication called pentoxifylline, when added to your regular ulcerative colitis treatment, might help reduce inflammation in your colon and improve your symptoms. Right now, patients typically take mesalamine (a standard anti-inflammatory medication) on its own. Researchers want to see if adding pentoxifylline to this treatment works better than mesalamine alone.

Ulcerative colitis is a chronic inflammatory disease that affects many people and can lead to serious complications like colon cancer. Current treatments don't work well enough for all patients, so doctors and researchers are looking for new combinations of medications that could help prevent the disease from getting worse and give patients better long-term health outcomes.